By Bob Katzen

Senate 11-26, rejected an amendment that supporters said would require that cannabis and cannabis product packaging include clear and accurate warning labels that address health risks, ensuring consumers are informed about potential effects. They noted that these effects include impairment, dependency or risks during pregnancy.

They noted the amendment expands labeling requirements by adding batch numbers, testing results, use-by dates, allergen information, THC amounts per serving and a required FDA disclaimer. They said this amendment requires rotating health warnings including risks like addiction, mood disorders, psychosis, suicidal thoughts and cannabinoid hyperemesis syndrome.

“Many other states already use similar warning-label requirements, and following those standards helps keep consumers informed and safe,” said amendment sponsor Sen. Patrick O’Connor (R-Weymouth). “It’s a practical step towards stronger public health.”

“Accidental marijuana ingestion poses serious and rising risks to children, especially since its legalization in Massachusetts,” said Sen. John Keenan (D-Quincy). “One study found that in 2020 unintentional cannabis exposure in children under five accounted for 41.6 percent of all poison control cases nationwide, I supported [this] amendment because its passage would have required clear labeling, similar to many other products, indicating that it is marijuana and is dangerous for children. It also would have included labels with information directed at adults, including THC level, a unique batch number, a full list of ingredients and potential allergens.”

Sen. Adam Gomez (D-Springfield) said the bill already includes robust labeling requirements and argued this amendment goes too far.

(A “Yes” vote is for the amendment. A “No” vote is against it.)

Sen. Patricia Jehlen No